For the first time, the U.S. Food and Drug Administration has approved a sleeping pill without restrictions warning doctors not to prescribe the medicine for long-term use. Lunesta, formerly referred to as Estorra, will be available in pharmacies in January. It will be marketed with a $60 million direct-to-consumer advertising campaign.
A $60 million ad campaign, uh ? What are the chances the average doctor will resist the pressure of his customers to prescribe the medicine for long-term use ? My take is: very few will. Don't worry though, if you have any apnea and your heart stops beating, you just need to have one of these defibrillators from amazon.com next to your bed and expect somebody to use it properly.
No comments:
Post a Comment